Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 2,941

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Kidney disease is associated with in-hospital death of patients with COVID-19

Open access
Cheng, Yichun, Luo, Ran, Wang, Kun, Zhang, Meng, Wang, Zhixiang, Dong, Lei, Li, Junhua, Yao, Ying, Ge, Shuwang, Xu, Gang·2020·Kidney International

Published version of a preprint

Abstract

Abstract Background Information on kidney impairment in patients with coronavirus disease 2019 (COVID-19) is limited. This study aims to assess the prevalence and impact of abnormal urine analysis and kidney dysfunction in hospitalized COVID-19 patients in Wuhan. Methods We conducted a consecutive cohort study of COVID-19 patients admitted in a tertiary teaching hospital with 3 branches following a major outbreak in Wuhan in 2020. Hematuria, proteinuria, serum creatinine concentration and other clinical parameters were extracted from the electronic hospitalization databases and laboratory databases. Incidence rate for acute kidney injury (AKI) was examined during the study period. Association between kidney impairment and in-hospital death was analyzed. Results We included 710 consecutive COVID-19 patients, 89 (12.3%) of whom died in hospital. The median age of the patients was 63 years (inter quartile range, 51-71), including 374 men and 336 women. On admission, 44% of patients have proteinuria hematuria and 26.9% have hematuria, and the prevalence of elevated serum creatinine and blood urea nitrogen were 15.5% and 14.1% respectively. During the study period, AKI occurred in 3.2% patients. Kaplan–Meier analysis demonstrated that patients with kidney impairment have higher risk for in-hospital death. Cox proportional hazard regression confirmed that elevated serum creatinine, elevated urea nitrogen, AKI, proteinuria and hematuria was an independent risk factor for in-hospital death after adjusting for age, sex, disease severity, leukocyte count and lymphocyte count. Conclusions The prevalence of kidney impairment (hematuria, proteinuria and kidney dysfunction) in hospitalized COVID-19 patients was high. After adjustment for confounders, kidney impairment indicators were associated with higher risk of in-hospital death. Clinicians should increase their awareness of kidney impairment in hospitalized COVID-19 patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.kint.2020.03.005

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 16

  1. Lu, 2020, Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding, Lancet, 395, 556, 10.1016/S0140-6736(20)30251-8 · DOI · Paper page
  2. Chu, 2005, Acute renal impairment in coronavirus-associated severe acute respiratory syndrome, Kidney Int, 67, 698, 10.1111/j.1523-1755.2005.67130.x · DOI · Paper page
  3. Tsang, 2003, A cluster of cases of severe acute respiratory syndrome in Hong Kong, N Engl J Med, 48, 1977, 10.1056/NEJMoa030666 · DOI · Paper page
  4. Betjes, 2013, Immune cell dysfunction and inflammation in end-stage renal disease, Nat Rev Nephrol, 9, 255, 10.1038/nrneph.2013.44 · DOI · Paper page
  5. Cohen-Hagai, 2016, Upper respiratory tract infection among dialysis patients, Isr Med Assoc J, 18, 557
  6. Sibbel, 2016, The clinical and economic burden of pneumonia in patients enrolled in Medicare receiving dialysis: a retrospective, observational cohort study, BMC Nephrol, 17, 199, 10.1186/s12882-016-0412-6 · doi:10.1186/s12882-016-0412-6
  7. Jung, 2011, Acute kidney injury in critically ill patients with pandemic influenza A pneumonia 2009 in Korea: a multicenter study, J Crit Care, 26, 577, 10.1016/j.jcrc.2011.02.012 · DOI
  8. Vanmassenhove, 2017, Management of patients at risk of acute kidney injury, Lancet, 389, 2139, 10.1016/S0140-6736(17)31329-6 · DOI · Paper page
  9. Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA, 323, 1061, 10.1001/jama.2020.1585 · DOI · Paper page
  10. Ge, 2016, Epidemiology and outcomes of acute kidney injury in elderly Chinese patients: a subgroup analysis from the EACH study, BMC Nephrol, 17, 136, 10.1186/s12882-016-0351-2 · DOI
  11. Yang, 2015, Acute kidney injury in China: a cross-sectional survey, Lancet, 386, 1465, 10.1016/S0140-6736(15)00344-X · DOI · Paper page
  12. Xu, 2015, Epidemiology and clinical correlates of AKI in Chinese hospitalized adults, Clin J Am Soc Nephrol, 10, 1510, 10.2215/CJN.02140215 · DOI · Paper page
  13. Peiris, 2003, Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study, Lancet, 361, 1767, 10.1016/S0140-6736(03)13412-5 · DOI · Paper page
  14. Russell, 2020, Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury, Lancet, 395, 473, 10.1016/S0140-6736(20)30317-2 · DOI · Paper page
  15. Shang, 2020, On the use of corticosteroids for 2019-nCoV pneumonia, Lancet, 395, 683, 10.1016/S0140-6736(20)30361-5 · DOI · Paper page
  16. 2012, KDIGO clinical practice guideline for Acute Kidney Injury, Kidney Int Suppl, 2, 1

Cited by

See all 2,941

Metadata

Authors
Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L., Li, J., Yao, Y., Ge, S., & Xu, G.
Venue
Kidney International
Publisher
Elsevier BV
Published
2020-05
Volume
97
Issue
5
Pages
829-838
ISSN
0085-2538 (ISSN-L)
OpenAlex
W3011605790
Cited by
2,941
References
10
FWCI
77.98
Type
journal article
Language
en
Open access
hybrid
Licence
Funders
  • National Natural Science Foundation of China (81670633, 81470948, 81570667, 91742204)
  • Tongji Hospital (TJ-C20200132)
  • National Key Research and Development Program of China (2016YFC0906103, 2015BAI12B07, 2018YFC1314003-1)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Kidney disease is associated with in-hospital death of patients with COVID-19. https://app.cochat.ai/papers/10.1016/j.kint.2020.03.005
The paper
Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L., Li, J., Yao, Y., Ge, S., & Xu, G. (2020). Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney International. https://doi.org/10.1016/j.kint.2020.03.005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.